BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kim MS, Jin YJ, Lee JW, Lee JI, Kim YS, Lee SY, Chae MH. Complete remission of advanced hepatocellular carcinoma by sorafenib: A case report. World J Gastrointest Oncol 2013; 5(2): 38-42 [PMID: 23556056 DOI: 10.4251/wjgo.v5.i2.38]
URL: https://www.wjgnet.com/1948-5182/full/v5/i2/38.htm
Number Citing Articles
1
Daizhong Liu, Aixiang Liu, Junping Peng, Yong Hu, Xielin Feng. Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenibEuropean Journal of Medical Research 2015; 20(1) doi: 10.1186/s40001-015-0085-9
2
Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun. Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive reviewClinical and Molecular Hepatology 2017; 23(4): 340 doi: 10.3350/cmh.2016.0070
3
Jung Gil Park, Won Young Tak, Soo Young Park, Young Oh Kweon, Se Young Jang, Soo Hyun Lee, Yu Rim Lee, Sun Kyung Jang, Keun Hur, Heon Ju Lee. Long-term follow-up of complete remission of advanced hepatocellular carcinoma following sorafenib therapy: A case reportOncology Letters 2017; 14(4): 4853 doi: 10.3892/ol.2017.6788
4
Naoki Morimoto, Norio Isoda, Toshiya Ootake, Shunji Watanabe, Mamiko Tsukui, Natsumi Miyata, Takuya Hirosawa, Nobuhiko Nagamine, Kentaro Sugano. Complete response induced by half dose of sorafenib administration in advanced hepatocellular carcinoma with peritoneal disseminationKanzo 2014; 55(2): 100 doi: 10.2957/kanzo.55.100
5
Jung Gil Park. Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapyClinical and Molecular Hepatology 2015; 21(3): 287 doi: 10.3350/cmh.2015.21.3.287
6
Norihito Nakano, Tomokazu Kawaoka, Hiroshi Aikata, Fumi Honda, Yuki Nakamura, Kei Morio, Masahiro Hatooka, Takayuki Fukuhara, Tomoki Kobayashi, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Shoichi Takahashi, Kazuaki Chayama. Complete response to short-term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastasesHepatology Research 2016; 46(13): 1402 doi: 10.1111/hepr.12698
7
Alessandra Bertacco, Alessandro Vitale, Claudia Mescoli, Umberto Cillo. Sorafenib treatment has the potential to downstage advanced hepatocellular carcinoma before liver resectionPersonalized Medicine 2020; 17(2): 83 doi: 10.2217/pme-2018-0114
8
Dong Hyun Kim, Eunae Cho, Sung Bum Cho, Sung Kyu Choi, Sunmin Kim, Jieun Yu, Young-Il Koh, Da Woon Sim, Chung Hwan Jun. Complete response of hepatocellular carcinoma with right atrium and pulmonary metastases treated by combined treatments (a possible treatment effect of natural killer cell)Medicine 2018; 97(42): e12866 doi: 10.1097/MD.0000000000012866